Status:

COMPLETED

Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC

Lead Sponsor:

Centocor Ortho Biotech Services, L.L.C.

Collaborating Sponsors:

Schering-Plough

Conditions:

Crohn Disease

Eligibility:

All Genders

21-99 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the safety and effectiveness of three different treatments for patients with Crohns disease who have not responded to previous treatment with a group of drugs co...

Detailed Description

Crohns disease is characterized by inflammation (the changes that happen when tissues in the body are injured) and ulceration (open sores) of the intestines. Crohns disease is treated with medications...

Eligibility Criteria

Inclusion

  • Diagnosis of Crohns Disease for at least 6 weeks
  • Moderate to severe disease activity (CDAI \>= 220 and \<=450)
  • No history of azathioprine, 6-MP (6 Mercaptopurine), or biologic treatments
  • Are either: Corticosteriod-dependent, OR considered for a 2nd (or greater) course of corticosteriod, OR 5-ASA failures, Or Budesonide failures

Exclusion

  • History of abdominal surgery within the last 6 months
  • Have an ostomy or stoma \[An operation to create an opening from an area inside the body to the outside\]
  • Are pregnant, nursing, or planning pregnancy (both men and women)
  • Serious simultaneous illness that could interfere with study participation
  • Use of any investigational drug within 30 days
  • Have a concomitant diagnosis or any history of congestive heart failure
  • Weigh more than 140 kilograms (or 310 pounds)

Key Trial Info

Start Date :

March 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

508 Patients enrolled

Trial Details

Trial ID

NCT00094458

Start Date

March 1 2005

End Date

December 1 2009

Last Update

February 9 2017

Active Locations (115)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 29 (115 locations)

1

Birmingham, Alabama, United States

2

Phoenix, Arizona, United States

3

Orange, California, United States

4

Roseville, California, United States